XERS
XERS
US98422E1038
Xeris Biopharma Holdings, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.91B EUR
1.37B EUR
1B EUR
1.3B EUR
Enterprise Value
2.03B EUR
1.54B EUR
1.15B EUR
1.45B EUR
Valuation Multiples
Trailing P/E
--
--
83.35x
133.5x
Forward P/E
28.32x
--
--
--
Price to Sales
5.7x
4.1x
3.18x
5.63x
Price to Book
--
--
76.92x
95.32x
EV/Revenue
6.04x
4.6x
3.65x
6.27x
EV/EBITDA
41.53x
28.21x
21.48x
35.32x
Price to FCF (P/FCF)
36.43x
24.7x
21.06x
34.36x
EV/FCF
38.62x
27.71x
24.15x
38.23x
FCF Yield
2.75%
4.05%
4.75%
2.91%
ende